An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Larkspur Health Acquisition Corp. (NASDAQ: LSPRU) informed that holders of its units can begin trading Class A Common Stock and redeemable warrants separately starting February 10, 2022. Units that are not separated will continue to trade under the symbol LSPRU, while those that are will be listed as LSPR for Class A Common Stock and LSPRW for warrants. Only whole warrants will be issued upon separation. The company focuses on mergers and acquisitions within the biotechnology sector.
Positive
None.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Larkspur Health Acquisition Corp. (NASDAQ: LSPRU, the “Company”) announced that the holders of the Company’s units may elect to separately trade the Class A Common Stock and redeemable warrants underlying such units commencing on February 10, 2022. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “LSPRU” and the Class A Common Stock and warrants that are separated will be listed on the Nasdaq Global Market and trade under the symbols “LSPR” and “LSPRW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of the Company’s units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate units into shares of Class A Common Stock and warrants.
About Larkspur Health Acquisition Corp.
Larkspur Health Acquisition Corp. is a blank check company whose business purpose is to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on companies in the biotechnology sector and would benefit from access to public markets and the operational and strategic expertise of our management team and board of directors. The Company is sponsored by Larkspur Health LLC, a Delaware limited liability company, and led by Chairman and Chief Executive Officer, Daniel J. O’Connor and Director and Chief Financial Officer, David S. Briones.
Forward Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of any future initial business combination, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.
